Related Experiment Video
Updated: May 5, 2026

Isolation of Neonatal Extrahepatic Cholangiocytes
Published on: June 5, 2014
ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy
R Müllenbach1, A Bennett, N Tetlow
1Maternal and Fetal Disease Group, 3rd Floor IRDB, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, UK.
Insights
Mutations in the ATP8B1 gene are linked to intrahepatic cholestasis of pregnancy (ICP). Magnetic resonance spectroscopy (MRS) suggests altered biliary phospholipids in ICP, offering a potential non-invasive assessment tool.
Area of Science:
- Genetics
- Hepatology
- Obstetrics
Background:
- Intrahepatic cholestasis of pregnancy (ICP) is a pregnancy complication affecting 0.7% of UK pregnancies, linked to adverse fetal outcomes.
- Homozygous ATP8B1 gene mutations cause specific cholestasis forms (PFIC1, BRIC) with normal gamma-GT.
- Investigating ATP8B1 mutations in ICP is crucial due to its association with fetal risks.
Purpose of the Study:
- To determine if ATP8B1 gene mutations are associated with ICP in British patients.
- To explore the potential role of ATP8B1 in the pathogenesis of ICP.
- To assess the utility of magnetic resonance spectroscopy (MRS) in evaluating liver and biliary constituents in ICP.
Main Methods:
- Sequence analysis of ATP8B1 coding exons in 16 ICP patients.
- Examination of 182 ICP patients and 120 controls for identified ATP8B1 variants.
- In vivo hepatic (31)P magnetic resonance spectroscopy (MRS) in eight ICP cases, including two with mutations.
Main Results:
- Two heterozygous ATP8B1 mutations (208G>A and 2599C>T) were identified in ICP cases.
- The 208G>A mutation was found in three ICP patients.
- MRS revealed significantly increased phosphodiester signals (p=0.03) and decreased phosphomonoester/phosphodiester ratios (p=0.04) in ICP patients compared to controls.
Conclusions:
- ATP8B1 mutations are demonstrated in intrahepatic cholestasis of pregnancy (ICP).
- MRS findings suggest a link between ICP susceptibility and elevated biliary phospholipids.
- MRS shows promise as a non-invasive method for assessing liver and biliary components in cholestatic conditions.
Background:
Intrahepatic cholestasis of pregnancy (ICP) affects approximately 0.7% of pregnancies in the UK and is associated with prematurity, fetal distress, and intrauterine death. Homozygous mutations in the ATP8B1 gene cause cholestasis with a normal serum gamma-glutamyl transpeptidase (gamma-GT), and have been reported in two forms of cholestasis: progressive familial intrahepatic cholestasis type 1 (PFIC1) and benign recurrent intrahepatic cholestasis (BRIC).
Aims:
To establish whether mutations in ATP8B1 are associated with ICP in British cases
Patients:
Sixteen well phenotyped women with ICP without raised gamma-GT were selected for sequence analysis. Subsequently, 182 patients and 120 controls were examined for the presence of the variants detected.
Methods:
All coding exons were sequenced in 16 cases. Eight ICP cases, including two women carrying a mutation, were investigated using in vivo hepatic (31)P magnetic resonance spectroscopy (MRS) RESULTS: Two heterozygous ATP8B1 transitions (208G>A and 2599C>T) that resulted in amino acid substitutions were identified; 208G>A was identified in three cases. MRS revealed an increased phosphodiester signal (Mann-Whitney U test, p = 0.03) and a decreased phosphomonoester/phosphodiester ratio (p = 0.04) in ICP cases compared with controls.
Conclusions:
We were able to demonstrate ATP8B1 mutations in ICP. MRS studies suggest that susceptibility to ICP is associated with a relative rise in biliary phospholipid. These data also suggest that MRS may be used for non-invasive assessment of the liver and biliary constituents in cholestasis.
Related Concept Videos
Animal Mitochondrial Genetics
ATP Synthase: Structure
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Cholecystitis
Chronic Pancreatitis I: Introduction

